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Abstract
Objective-To assess the association of lichen
planus with liver complaints and with known aetio-
logical factors of liver diseases.
Design-Multicentre case-control study. Inter-
views were conducted by trained medical inves-
tigators on the basis of a structured questionnaire.
At the interview patients and controls were asked for
consent to blood samples being taken to determine
transaminase activities and the presence of hepatitis
B virus surface antigen.
Setting-Outpatient departments of 27 Italian
general and teaching hospitals that were collaborat-
ing in the Gruppo Italiano Studi Epidemiologici in
Dermatologia (GISED).
Subjects-Incident cases and controls were
eligible. A total of 577 patients with lichen planus and
1031 controls with dermatological diseases other
than lichen planus were interviewed. Less than 1% of
the people contacted refused to participate. Patients
and controls were matched for sex and age in five
year intervals.
Results-The risk of lichen planus was higher in
patients with a history of liver diseases requiring
hospital admission or specialist consultation (rela-
tive risk=1-6; 95% confidence interval=1-2 to 2.2),
those who had had liver biopsy (5.5; 1*9 to 15-6), and
those with a history of viral hepatitis (1.9; 1 -1 to 3-1).
High activities of liver enzymes and positive results
oftests for hepatitis B virus surface antigen were also
associated with lichen planus. The association with
alcohol consumption was not clearly confirmed by a
dose-risk relation.
Conclusion-This study adds quantitative epi-
demiological evidence to the clinical observation
that liver disease is a risk factor for lichen planus
although not a specific marker of it.
Introduction
Lichen planus is a relatively common benign
disease. Its clinical features are characteristic and affect
both skin and mucous membranes. Skin lesions vary
according to their location, being flat papules on the
flexor surface of the wrist, verrucous lesions on the
shin, and alopecic patches that leave scars on the hairy
regions. Mucosal lesions are more uniform and usually
present as whitish striae and, occasionally, as erosions.
Results of histopathology are distinctive, with a band
like lymphocytic infiltrate in the upper dermis that
attacks the basal cell layer, destroying the normal
architecture of the epidermis. ' Thickening of the
malpighian bodies, especially in the granular layer, is
an additional feature. The aetiology of lichen planus is
largely unknown. Its association with HLA -BW16,
B8, and DRI suggests the possibility of genetic pre-
disposition.2 HLA-DR1 is concerned in regulation
of the immune response, and lichen planus has been
found to be clinically associated with some immune
related diseases, such as myasthenia gravis, ulcerative
colitis, hypogammaglobulinaemia, thymoma, and
alopecia areata.3-7 To our knowledge there are, how-
ever, no clear epidemiological data on this issue.8
In recent years attention has been drawn to the
possible association of lichen planus with chronic liver
diseases-namely, primary biliary cirrhosis and
chronic active hepatitis.9 '5 Initially considered as an
adverse reaction to penicillamine used to treat primary
biliary cirrhosis, lichen planus was later reported to be
associated with primary biliary cirrhosis indepen-
dently of the drug. Evidence for an association with
chronic active hepatitis is as controversial now as it was
after the first short series of patients with lichen
erosivus and liver cirrhosis was described. The overall
prevalence of chronic active hepatitis in patients with
lichen planus varies in different studies from 11-30 '1to
0. 1%.14
In view of these uncertainties we did an epidemio-
logical study of lichen planus. The aim of the study, in
which 27 dermatological centres in Italy that were
collaborating in the Gruppo Italiano Studi Epidemio-
logici in Dermatologia participated, was to assess the
association of lichen planus with liver complaints and
with known aetiological factors of liver diseases.
Subjects and methods
This multicentre case-control study was carried out
in the outpatient departments of 27 Italian general and
teaching hospitals: 17 were located in northern Italy
(75-4% of the patients and 76-7% of the controls) and
10 in central and southern Italy (24-6% of the patients
and 23 3% of the controls).
Between September 1986 and December 1987
trained medical interviewers identified and questioned
patients with lichen planus and controls by using a
structured questionnaire. The interviewers had had
biomedical training and had experience in medical
interviewing; the study coordinators reviewed each
interviewer's report to evaluate the completeness and
internal consistency of the data collected.
Information was obtained on sociodemographic
factors and personal characteristics and habits (includ-
ing smoking habits and alcohol consumption) and
medical history of liver disorders, including data on
any specialist consultations or hospital stays for liver
complaints, a blood transfusion, or acute viral hepatitis.
We computed the average consumption of alcohol
each day for patients and controls assuming a compar-
able pure alcohol content in each type of drink (that is,
150 ml of wine=330 ml of beer=30 ml of spirits=
10-12 g ofpure alcohol). Wine accounted for more than
90% of all of the alcohol consumed in this population.
At the interview patients and controls were asked
for consent to blood samples being taken to determine
alanine aminotransferase and aspartate amino-
transferase activities and the presence of hepatitis B
virus surface antigen. Oral informed consent was
obtained from each subject before data or samples were
collected.
The patients had been diagnosed consecutively in
the participating centres as having lichen planus
(incident cases). Histopathological sections stained
with haematoxylin-eosin were required in patients
with lesions confined to the mucosae, lichen planus
verrucosus, and lichen planopilaris and were reviewed
by a dermatopathologist (GZ). A total of 577 patients
aged 15-85 (median 50) years were interviewed; 528
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(91 5%) had lichen planus of the skin or the mucous
membranes, 18 (3 1 %) erosive lichen planus of mucous
membranes, 15 (266%) hypertrophic lichen planus,
and 16 (288%) other varieties of lichen planus. Only
four of the patients initially ontacted refused the
interview. The controls were the first two patients of
the same sex and in the same five year age category seen
for a dermatological complaint (that they had not had
diagnosed previously) in the same centre after a patient
with lichen planus. In six centres, however, only one
control was selected for each of 123 patients. If a
control refused the interview the next eligible subject
was selected. Only nine controls refused to participate.
Subjects were not included if they were attending for
autoimmune disorders or for other diseases associated
with liver dysfunction (for example, lupus erythema-
tosus, porphyria cutanea tarda). In all, 1031 controls,
aged 16-88 (median 47) years, were included in the
analysis; 233 had been examined for eczema, 124 for
pityriasis rosea, 106 for urticaria, 88 for psoriasis, 78
for neoplastic diseases, 65 for exanthema, 51 for skin
infections, 24 for burns, and 262 for other skin
diseases. Table I gives the distribution of patients and
controls according to age and sex.
TABLE I-Number (percentage) of patients with lichen planus (n=
577) and controls (n= 1031) according to age and sex
Patients Controls
Men 296(51-3) 529(51-3)
Women 281 (48-7) 502 (48 7)
Age (years):
<20 29 (5-0) 90 (8-7)
20-49 286 (49 6) 497 (48-2)
-50 262 (45 4) 444 (43 1)
We derived the relative risks of lichen planus,
together with their 95% confidence intervals,'6 from
data stratified for age and sex by the Mantel-Haenszel
procedure.' Furthermore, to allow simultaneously for
the effects of differences among the centres and several
potential confounding factors we used unconditional
multiple logistic regression, fitted by the method of
maximum likelihood. 8 Estimates derived from uncon-
ditional regression are probably conservative com-
pared with those obtained using the matched
approach. The differences, however, are generally
negligible, and the analysis included several variables
that were not considered in the matched design.
Therefore we chose to use analyses that disregarded
matching for age and sex. Included in the regression
equations were terms for age, sex, centre, education,
alcohol consumption, smoking habits, blood alanine
aminotransferase and aspartate aminotransferase
activities, presence of hepatitis B virus surface antigen,
history of liver diseases, results of liver biopsy, and
presence of acute viral hepatitis.
Results
Table II shows the distribution of patients and
controls according to history of liver complaints
requiring a specialist consultation or hospital stay or
liver biopsy; the corresponding relative risks were 1 6
TABLE II-Relative risks of lichen planus according to liver diseases
and having had liver biopsy*
Relative riskt
(95% confidence
Patients Controls interval)
Liver disease 124/577 138/1022 16 (12 to 2-2)
Liver biopsy 16/571 5/1000 5-5 (1-9 to 15 6)
Acuteviralhepatitis 35/574 36/1029 1-9(1 1 to3 1)
Data were missing for some patients and controls.
t Estimates from multiple logistic regression equation, including terms for
age, sex, centre, education, alcohol consumption, and smoking habits.
(95% confidence interval 1-2 to 2 2) and 5 5 (1 9 to
15 6). The risk of lichen planus was also increased in
patients with a history of acute viral hepatitis (relative
risk 19; 1 1 to 3 1). In the patients, chronic active
hepatitis was diagnosed (and confirmed by the results
of histology) in three patients and primary biliary
cirrhosis was diagnosed in only one; in the controls one
diagnosis of chronic active hepatitis and one of primary
biliary cirrhosis were reported. These differences were
not significant. The results of liver biopsy also gave the
following diagnoses: fatty liver infiltration (four
patients and one control), cirrhosis (five patients and
two controls), acute hepatitis (two patients), and
hepatic carcinoma (one patient).
Results of assays of alanine aminotransferase and
aspartate aminotransferase activities and of tests for
hepatitis B surface antigen (table III) were consistent
with the above findings. In subjects with raised alanine
TABLE III-Relative risks of lichen planus according to alanine
aminotransferase and aspartate aminotransferase activities and result
of testfor hepatitis B surface antigen*
Relative riskt
(95% confidence
Patients Controls interval)
Alanine aminotransferase
>50U/l 70/577 69/1030 19(13to2-7)
Aspartate amino-
transferase >50 U/I 36/577 26/1030 21(1-3 to 36)
Positive for hepatitis B
surface antigen 26/561 27/1008 1-8 (10 to 32)
* Data were missing for some patients and controls.
tEstimates from multiple logistic regression equation, including terms for
age, sex, centre, education, alcohol consumption, and smoking habits.
aminotransferase and aspartate aminotransferase
activities (B50 U/1) the relative risk of lichen planus
was about twice that in subjects with normal activities
(<50 U/1), the values being 1-9 (95% confidence
interval 1-3 to 2 7) and 2-1 (1-3 to 3 6) for the two
enzymes respectively. In subjects positive for hepatitis
B virus surface antigen the estimated relative risk,
compared with those with a negative test result, was
1-8 (10 to 3-2).
Table IV presents the relation between alcohol
consumption and lichen planus. The proportion of
those who ever drank alcohol was slightly higher in
patients (73-8% of patients v 68 6% of controls), but
there was no evidence of a dose related risk. The
estimated relative risk of lichen planus was 14 for
subjects who reported drinking one or two alcoholic
drinks each day and 1 4 for those who drank three or
more; the trend in risk was not significant.
TABLE Iv-Relative risks of lichen planus according to alcohol
consumptwn*
Relative risk:
Average consumption of (95% confidence
alcohol (drinks per day)t Patients Controls interval)
Never or occasional 147 316
1-2 264 434 1 4(1-1 to 1-7)
>3 150 258 14 (I 0 to 19)
y =3-2; p=0 07.
* Data were missing for 16 patients and 23 controls.
tI drink=150 ml of wine= 330 ml of beer=30 ml of spirits=10- 12 g of
alcohol.
tEstimates from multiple logistic regression equation, including terms for
age, sex, centre, education, smoking habits, and history of liver diseases.
Discussion
Our results provide quantitative epidemiological
backing for the suggested clinical relation between
liver diseases and lichen planus." 19 A self reported
history of a liver complaint (that is, acute viral hepatitis
or a hospital stay or specialist referral for liver dis-
orders), raised alanine aminotransferase and aspartate
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aminotransferase activities, and a positive result for
hepatitis B virus surface antigen about doubled the risk
of lichen planus. A history of having had liver biopsy
gave an estimated risk of lichen planus of about five.
Potential sources of bias should be considered in
interpreting these findings. Data were collected in 27
different centres and patients and controls were drawn
from hospitals and institutions covering comparable
catchment areas, the rate of participation was almost
complete, and a detailed inspection of the data showed
that the association was consistent in various centres
and geographical areas. It is unlikely that the
cutaneous disease of the patients and controls in-
fluenced the reporting of liver disease; recall bias can
hardly affect such variables as whether the patient had
had a hospital stay, liver biopsy, or history of viral
hepatitis, and the possible relation between lichen
planus and liver diseases was probably not known to
the subjects interviewed. The association was con-
firmed by the results for alanine aminotransferase and
aspartate aminotransferase activities and positive
results for hepatitis B virus surface antigen at the time
of the interview. These findings could also hardly be
explained by confounding, as allowance for major
potential distorting factors (including socioeconomic
state and alcohol consumption) did not appreciably
change the estimated relative risks. As our controls had
dermatological conditions they were comparable with
the patients in relation to major determinants for
seeking medical advice. Studies have suggested that
psoriasis might be associated with alcohol consump-
tion and liver diseases"9 3; the inclusion of controls with
psoriasis in our study may, therefore, have tended to
cause any association with these variables to be under-
estimated. Analysis of our data excluding these con-
trols did not, however, change the estimated relative
risks. Finally, it is reassuring that the association was
stronger for the strongest clinical variable (history of
liver biopsy), although the number of subjects was
small.
The association of lichen planus with liver diseases
has already been suggested chiefly on the basis of
anecdotal reports or clinical series. Rebora and Ron-
gioletti, in a retrospective study, contacted 44 patients
who had been managed over 26 years in their derma-
tological unit. In all, 11 3% of their patients with lichen
planus had had chronic active hepatitis, exceeding the
expected prevalence of chronic liver disorders in their
geographical area." In a study from the Mayo Clinic 24
patients with primary biliary cirrhosis and lichen
planus were identified, seven of whom had not been
treated with penicillamine.'8 The same research group
was not able to confirm the association of lichen planus
with chronic active hepatitis observed by Rebora and
Rongioletti. Based on a computerised review of cases of
lichen planus seen over 31 years, they found that only
four patients (0 10% of the total number seen) had had
chronic active hepatitis diagnosed at any time during
that period. 14 Korkij et al, in a case-control study of 136
patients with lichen planus and 272 controls, observed
an excess of liver abnormalities in the patients, three of
whom had chronic active hepatitis."
Our study was focused on a broad spectrum of liver
abnormalities in patients with lichen planus. We
confirmed the association of lichen planus with liver
diseases. Clinically, however, liver disease in such
patients is difficult to define, escapes specific diagnosis,
and extends over a long period, explaining the excess
number having had liver biopsy.
Our data are difficult to interpret biologically as the
association between lichen planus and liver disorders
apparently is not restricted to a single specific aetiologi-
cal factor, and liver disorders in our study were a
poorly defined entity. Moreover, the association with
liver disease is relatively limited in terms of relative
risks (between 1 5 and 2 for various indicators), and
hence, in terms of attributable risk, it could explain
only a small fraction of the cases of lichen planus (about
10%). Thus other factors probably play a part in the
pathogenesis of the disease. Even though hepatitis B
virus surface antigen was associated with lichen
planus, it is difficult to accept that lichen planus is one
of the clinical expressions of hepatitis B virus infection.
In fact, the increased risk of lichen planus in patients
with liver disorders (high transaminase activities) was
still significant after adjustment for a positive result for
hepatitis B virus surface antigen and a history of viral
hepatitis (data not presented). We suggest that there
may be an indirect relation, for instance, between
lichen planus and other hepatotropic viruses that are
possibly transmitted in a way similar to hepatitis B
virus such as non-A non-B hepatitis, cytomegalovirus,
and Epstein-Barr virus. Lichen planus could be a
stereotypic cell mediated reaction to either a specific
virus or several viruses, some of them hepatotropic.
Alcohol consumption seems to be associated to some
extent with lichen planus. The risk did not, however,
increase with increasing exposure. Alcohol may be a
cofactor in inducing hepatic damage, but our finding
may have been due to a poorly controlled confounding
effect.
A reaction very similar to lichen planus is observed
in chronic graft versus host disease,3' biopsy specimens
of the liver showing various changes. Initially, mixed
inflammatory cells, consisting predominantly of
lymphocytes, infiltrate the portal zones; later, portal
fibrosis develops, leading to bile duct atresia. Chronic
graft versus host disease that occurs after a period of
engraftment seems to be produced by cells that dif-
ferentiate within the host and to be a syndrome of
disordered immune regulation with features of
immunodeficiency and autoimmunity.'233
Although these biological interpretations seem at
present too vague or speculative to provide plausible
explanations for our epidemiological observations,
their uncertainties do not eclipse the findings of this
study-that is, the association between various in-
dicators of liver disease and the risk of lichen planus.
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Abstract
In medical research data are often collected serially
on subjects. The statistical analysis of such data is
often inadequate in two ways: it may fail to settle
clinically relevant questions and it may be statistically
invalid. A commonly used method which compares
groups at a series oftime points, possibly with t tests,
is flawed on both counts. There may, however, be a
remedy, which takes the form of a two stage method
that uses summary measures. In the first stage a
suitable summary of the response in an individual,
such as a rate of change or an area under a curve, is
identified and calculated for each subject. In the
second stage these summary measures are analysed
by simple statistical techniques as though they were
raw data. The method is statistically valid and likely
to be more relevant to the study questions. If this
method is borne in mind when the experiment is
being planned it should promote studies with enough
subjects and sufficient observations at critical times
to enable useful conclusions to be drawn.
Use of summary measures to analyse serial
measurements, though not new, is potentially a
useful and simple tool in medical research.
Introduction
A common study design in medical research is to
give patients some intervention and then observe what
happens to them over time. For example, blood
glucose concentrations may be measured several times
after a glucose drink. In many cases there may be more
than one group of patients, possibly randomised to
different treatments. Despite its apparent simplicity
the analysis of this form of study presents statistical
problems which, judged from published work, are not
widely appreciated. The purpose of this paper is to
propose a general simple method for a clinically useful
and statistically valid analysis. We consider only
studies in which each patient receives a single treatment
or intervention, so excluding escalating dose studies
or crossover trials which require more complicated
analysis. Though we also restrict attention to outcome
variables that are quantitative because these occur
most commonly, the methods can also be applied to
ordered data such as pain scores.
Types of time dependency
It is helpful to distinguish two main ways in which
the outcome variable may change with time.
Peaked-In many studies the outcome variable
starts from a baseline (sometimes zero), rises to a peak,
and then returns to baseline. This is displayed as a
peaked curve (fig 1). For example, in a study of post
prandial energy expenditure during pregnancy the
metabolic rate was measured in women after a 12 hour
fast and then at 30 minute intervals for two hours in
response to a test meal.' This was done during
pregnancy and again once lactation had stopped. The
metabolic rate rose to a peak after about 60 minutes and
then fell steadily. Women were found to have a
reduced energy expenditure during pregnancy. In that
study the interest lay in both the total response and the
time to reach the maximum value.
Growth-Sometimes the outcome variable steadily
increases or decreases with time and does not start to
return to its initial value over the period of study. This
is displayed as a growth curve (fig 1). A recent study
investigated the role of peripheral vascular tone in
230 BMJ VOLUME 300 27 JANUARY 1990
